Unum
UNM
$82.77
+1.38%
Unum Group is a leading provider of group and individual income protection insurance products, operating primarily in the United States, the United Kingdom, and Poland. The company is a dominant player in the domestic disability insurance market, with a significant portion of its premiums derived from employer-sponsored plans, complemented by offerings in long-term care, life insurance, and other employee benefits. The current investor narrative centers on the company's ability to execute a strategic turnaround, with recent news highlighting the potential for significant upside if management can successfully drive premium growth, stabilize margins, and effectively deploy capital through share buybacks.…
UNM
Unum
$82.77
Related headlines
Investment Opinion: Should I buy UNM Today?
Rating: Hold. The core thesis is that UNM offers a deeply undervalued forward multiple and defensive characteristics, but these are counterbalanced by fundamental instability and poor growth, warranting a neutral stance pending clearer evidence of a turnaround.
Supporting evidence includes a forward PE of 8.37x implying significant earnings growth, a sustainable 2.29% dividend yield supported by $555.4M in annual FCF, a fortress balance sheet with a 0.35 debt-to-equity ratio, and strong recent price momentum of 13.96% over three months. However, these positives are offset by anemic 1.25% revenue growth, severe net margin compression from 10.88% to 5.37%, and massive long-term underperformance versus the broader market.
The thesis would upgrade to a Buy if the forward PE compressed further toward 7x alongside evidence of margin stabilization (e.g., net margin recovering above 8%) or if revenue growth accelerated above 5%. It would downgrade to a Sell if quarterly earnings volatility intensified, pushing the trailing PE above 25x while growth remained stagnant, or if the stock broke below key technical support at $68.28. Relative to its own volatile history and defensive peer set, the stock appears fairly valued, trading the promise of a turnaround against demonstrable operational challenges.
Sign up to view all
UNM 12-Month Price Forecast
UNM presents a classic value trap scenario: superficially cheap but with fundamental flaws. The forward PE of 8.37x is compelling and suggests significant upside if earnings meet forecasts, but the severe volatility in profitability (net margin halved year-over-year) makes those forecasts highly unreliable. The stock's low beta and dividend offer defensive appeal, yet its chronic underperformance versus the market is a major red flag. The stance would upgrade to bullish on confirmation of sustained margin improvement and revenue acceleration above 3%. It would turn bearish if the next earnings report shows further margin deterioration, proving the turnaround narrative is failing.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Unum's 12-month outlook, with a consensus price target around $107.60 and implied upside of +30.0% versus the current price.
Average Target
$107.60
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$66 - $108
Analyst target range
Analyst coverage for Unum appears limited, with only two analysts providing estimates for revenue and EPS, indicating this is not a widely followed large-cap name; this limited coverage can lead to higher volatility and less efficient price discovery. The consensus sentiment, based on recent institutional ratings, is mixed but leans cautiously positive, with firms like Wells Fargo and Barclays maintaining 'Overweight' ratings, while Morgan Stanley, UBS, and JP Morgan hold 'Neutral' or 'Equal Weight' stances, reflecting a balanced view with a slight bullish tilt. The wide dispersion in historical quarterly PE ratios, from 3.80x to 83.39x, underscores the high uncertainty and lack of strong consensus on the company's earnings power, which is typical for stocks with thinner analyst coverage; investors must therefore rely more heavily on their own fundamental and valuation analysis.
Bulls vs Bears: UNM Investment Factors
The bull case for UNM rests on a compelling valuation disconnect—a forward PE of 8.37x pricing in excessive pessimism—coupled with strong capital returns and a defensive low-beta profile. The bear case highlights fundamental instability, with wildly fluctuating earnings margins and stagnant revenue growth undermining the turnaround thesis. Currently, the bull side holds stronger evidence due to the extreme valuation discount and robust financial health, but the investment debate hinges entirely on management's ability to stabilize profitability. The single most important tension is whether the company can deliver consistent earnings growth to justify the forward multiple's implied optimism, or if margin volatility will persist, trapping the stock in its historical valuation range.
Bullish
- Deeply Undervalued Forward PE: The stock trades at a forward PE of 8.37x, which is less than half its trailing PE of 18.10x. This significant discount implies the market expects a substantial earnings recovery, offering a wide margin of safety if management executes its turnaround plan.
- Strong Capital Return & Financial Health: The company generates robust free cash flow of $555.4M TTM, supporting a 2.29% dividend yield with a sustainable 41.46% payout ratio. A low debt-to-equity ratio of 0.35 provides a conservative balance sheet and ample capacity for the share buybacks highlighted in recent strategic news.
- Defensive Low-Beta Profile: With a beta of 0.231, UNM exhibits only 23% of the market's volatility. This makes it a compelling defensive holding, particularly in uncertain markets, as evidenced by its 13.96% 3-month gain outperforming the S&P 500's 8.42% rise.
- Technical Momentum Near Breakout: The stock is trading at $81.64, just 1.8% below its 52-week high of $83.13. A decisive breakout above this resistance level, supported by a 3.47% gain over the past month, could signal a continuation of the bullish trend and attract technical buying.
Bearish
- Severe Earnings Volatility & Margin Compression: Profitability is highly inconsistent, with Q4 2025 net margin collapsing to 5.37% from 10.88% a year prior. Quarterly EPS has swung from $1.93 to $0.23, indicating fundamental instability that undermines reliable earnings projections.
- Stagnant Top-Line Growth: Revenue growth is anemic at 1.25% YoY in Q4 2025, and sequential revenue declined from $3.36B in Q3. This lack of meaningful premium growth challenges the core turnaround narrative and limits multiple expansion potential.
- Limited Analyst Coverage & Sentiment: Only two analysts provide estimates, indicating low institutional interest and potentially inefficient price discovery. The wide historical PE range (3.80x to 83.39x) reflects a lack of consensus on normalized earnings, increasing uncertainty for investors.
- Relative Underperformance vs. Market: Despite recent strength, UNM's 1-year return of 1.08% massively underperforms the S&P 500's 25.19% gain, a -24.1% relative strength gap. This suggests the stock has been a significant laggard in a bull market, failing to capture broader investor enthusiasm.
UNM Technical Analysis
The stock is in a sustained uptrend over the medium term, evidenced by a 13.96% gain over the past three months, though its one-year performance of 1.08% indicates a more muted longer-term trend. Currently trading at $81.64, the price sits at approximately 90% of its 52-week range ($68.28 to $83.13), positioning it near recent highs and suggesting strong momentum but also potential for overextension if it fails to break through the $83.13 resistance level. Recent momentum is robust, with the stock up 3.47% over the past month, which aligns with and accelerates the positive three-month trend, indicating no significant divergence that would signal an imminent reversal. The stock's beta of 0.231 indicates it is significantly less volatile than the broader market, which is a critical factor for risk-averse investors seeking defensive exposure within the financial sector. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $83.13 and support at the 52-week low of $68.28; a decisive breakout above resistance could signal a continuation of the bullish trend, while a failure and reversal might lead to a test of lower support levels given the stock's low volatility profile.
Beta
0.23
0.23x market volatility
Max Drawdown
-16.6%
Largest decline past year
52-Week Range
$68-$83
Price range past year
Annual Return
+0.8%
Cumulative gain past year
| Period | UNM Return | S&P 500 |
|---|---|---|
| 1m | +3.9% | +4.0% |
| 3m | +13.5% | +8.2% |
| 6m | +8.2% | +11.5% |
| 1y | +0.8% | +24.3% |
| ytd | +7.2% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
UNM Fundamental Analysis
Revenue growth is modest but positive, with the most recent quarterly revenue of $3.24 billion representing a 1.25% year-over-year increase; however, examining the multi-quarter trend reveals volatility, as revenue dipped from $3.36 billion in Q3 2025, indicating potential near-term pressure on top-line expansion. The company is profitable, reporting net income of $174.1 million for the quarter, but profitability metrics show significant fluctuation, with the net margin at 5.37% for Q4 2025, which is substantially lower than the 10.88% net margin reported in Q4 2024, highlighting margin compression. Gross margin for the latest quarter was 41.62%, which is healthy for an insurer, but the operating margin of 6.74% suggests high operating expenses are pressuring bottom-line results. The balance sheet is conservatively managed, with a low debt-to-equity ratio of 0.35, indicating minimal financial leverage risk. The company generates substantial cash flow, with trailing twelve-month free cash flow of $555.4 million, providing ample liquidity to fund operations, dividends (payout ratio of 41.46%), and the share repurchases highlighted in recent news, supporting a stable financial health profile.
Quarterly Revenue
$3.2B
2025-12
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.41%
Latest Quarter
Free Cash Flow
$555400000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is UNM Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. Unum trades at a trailing PE of 18.10x and a forward PE of 8.37x, with the significant discount in the forward multiple implying the market expects a substantial recovery in earnings over the next twelve months. Compared to sector averages, the trailing PE of 18.10x is likely at a discount to many financial services peers, though specific industry average data is not provided; the forward PE of 8.37x appears deeply undervalued if earnings projections materialize, suggesting the market may be pricing in excessive pessimism. Historically, the stock's own trailing PE has ranged widely, from as low as 3.80x to over 83x in recent quarters; the current 18.10x is above the multi-year median evident in the data, indicating the stock is not at bargain-basement levels relative to its own history, but the low forward PE suggests expectations for significant multiple compression if earnings grow as anticipated.
PE
18.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~83x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on severe earnings volatility and margin pressure. The net margin collapsed from 10.88% in Q4 2024 to 5.37% in Q4 2025, and quarterly EPS has swung from $1.93 to $0.23, indicating an unreliable earnings stream. While the balance sheet is conservative with a 0.35 debt-to-equity ratio, the company's valuation (forward PE of 8.37x) is entirely dependent on a significant earnings recovery; failure to stabilize margins would invalidate the primary investment thesis.
Market & Competitive Risks include valuation compression and sector neglect. The stock's trailing PE of 18.10x is above its multi-year median, and while the forward multiple is low, it could expand further if growth fails to materialize. With a beta of 0.231, UNM is highly defensive but has dramatically underperformed the market (1.08% vs. 25.19% over one year), indicating it is out of favor. Limited analyst coverage (only 2 analysts) exacerbates these risks, leading to lower liquidity and potentially exaggerated moves on news.
Worst-Case Scenario involves a failure of the strategic turnaround, triggering a re-rating to historical distress valuations. If premium growth stalls and margin compression continues, earnings estimates could be cut, causing the forward PE to re-base higher as the denominator shrinks. Coupled with a loss of investor confidence, this could drive the stock back toward its 52-week low of $68.28. From the current price of $81.64, this represents a realistic downside of approximately -16.4%, consistent with the stock's recent maximum drawdown of -16.57%.
FAQ
The primary risks are, in order of severity: 1) Operational Risk: Extreme earnings volatility, as seen in the net margin halving to 5.37%, makes future profits unpredictable. 2) Growth Risk: Anemic 1.25% revenue growth challenges the core business narrative. 3) Market Risk: Chronic underperformance, with a -24.1% relative strength gap versus the S&P 500 over one year, suggests the stock is out of favor. 4) Liquidity/Sentiment Risk: Limited coverage from only two analysts can lead to exaggerated price swings and inefficient discovery.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $78 and $88, muddling through with volatile earnings. The Bull Case (30% probability) targets $90 to $100 on successful execution of the turnaround plan. The Bear Case (20% probability) risks a drop to the $68 to $75 range if operational challenges worsen. The base case is most likely, anchored by the stock's defensive yield and valuation support, but contingent on management preventing further margin erosion.
UNM sends mixed valuation signals. It appears deeply undervalued on a forward basis, trading at a PE of 8.37x, which implies a major earnings recovery. However, its trailing PE of 18.10x is above its own historical median, and this premium is unjustified given the company's 1.25% revenue growth. Compared to defensive financial peers, the stock is likely fairly valued, trading a low multiple for low growth. The current valuation implies the market expects management to successfully execute its turnaround to stabilize profits.
UNM is a conditional buy for specific investor profiles. The forward PE of 8.37x offers a substantial margin of safety and the 2.29% dividend is well-covered by strong free cash flow. However, the stock carries significant risk due to severe earnings volatility, with net margin collapsing from 10.88% to 5.37% year-over-year. It is a good buy for defensive, income-focused investors willing to bet on a slow corporate turnaround, but not suitable for growth-oriented investors or those requiring stable, predictable earnings.
UNM is primarily suited for a long-term investment horizon of 3-5 years. Its low beta of 0.231 and dividend policy make it a poor candidate for short-term trading, as it typically lacks the volatility and momentum for quick gains. The investment thesis is based on a gradual corporate turnaround and capital return story, which requires time to unfold. However, given the fundamental volatility, investors should be prepared for a bumpy ride and consider it a core holding for the defensive, income-generating portion of a portfolio rather than a tactical trade.